Frankfurt - Delayed Quote ? EUR Kenvue Inc. (J4D.F) Follow Compare 21.98 +0.46 (+2.14%) At close: November 15 at 3:29 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations There May Be Reason For Hope In Kenvue's (NYSE:KVUE) Disappointing Earnings Kenvue Inc.'s ( NYSE:KVUE ) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed... Simply Wall St. ? 2 days ago KVUE 3 US Stocks Estimated Up To 31.4% Below Intrinsic Value As the U.S. stock market continues to reach record highs, fueled by a post-election rally and optimism surrounding potential policy changes, investors are keenly focused on identifying opportunities that may still be undervalued amidst this bullish environment. In such a thriving market, finding stocks trading below their intrinsic value can offer significant potential for growth as these companies may not yet reflect their full worth in the current pricing landscape. Simply Wall St. ? 6 days ago CPAY KVUE LLY Kenvue Third Quarter 2024 Earnings: EPS Misses Expectations Kenvue ( NYSE:KVUE ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.90b (flat on 3Q 2023). Net income... Simply Wall St. ? 7 days ago KVUE Kenvue Inc (KVUE) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Market Challenges Kenvue Inc (KVUE) reports modest organic growth and strategic investments, while addressing challenges in the skin health and beauty segment. GuruFocus.com ? 9 days ago KVUE Kenvue Inc. (KVUE): Expanded Production and Trusted Brands Drive Growth We recently published a list of 8 Best Consumer Staples Stocks To Buy Right Now. In this article, we are going to take a look at where Kenvue Inc. (NYSE:KVUE) stands against other best consumer staples stocks to buy right now. Consumer spending plays a significant role in the economy, according to the U.S. Bureau […] Insider Monkey ? 9 days ago KVUE Kenvue (KVUE) Q3 2024 Earnings Call Transcript KVUE earnings call for the period ending September 30, 2024. Motley Fool ? 9 days ago KVUE Kenvue's falling skin health sales hit earnings again (Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on Thursday, marking the fifth consecutive quarter of year-over-year decline in its core skin health and beauty products segment. Kenvue said it is trying to improve sales by spending more on marketing and supplying additional units of its skincare products to stores. The division's sales fell 4.2% to $1.07 billion, short of the analyst consensus estimate of $1.10 billion, according to data compiled by LSEG, which Kenvue said was due to muted demand for sunscreens and related products in the reported quarter. Reuters ? 10 days ago KVUE Kenvue Reports Third Quarter 2024 Results SKILLMAN, N.J., November 07, 2024--Kenvue Inc. (NYSE: KVUE) ("Kenvue"), today announced financial results for the fiscal third quarter ended September 29, 2024. Business Wire ? 10 days ago KVUE Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines Kenvue Canada Inc., a division of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world's largest pure-play consumer health company by revenue and maker of iconic brands such as Tylenol?, Aveeno, Listerine? and Neutrogena?, announced the completion of its newly expanded manufacturing facility in Guelph. This expansion marks a significant milestone in Kenvue's more than 50-year commitment to the region and strengthening supply resilience globally. CNW Group ? 12 days ago KVUE Neutrogena? Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists SKILLMAN, N.J., October 31, 2024--Kenvue Inc. (NYSE: KVUE) today announced Neutrogena? is establishing multi-year partnerships with Dr. Dhaval Bhanusali, and Dr. Muneeb Shah. Business Wire ? 16 days ago KVUE The Score: McDonald’s, Tesla, Spirit Airlines and More Stocks That Defined the Week An activist investor wants a J&J spinoff to boost its stock price. The hedge fund Starboard Value has taken a sizable stake in Kenvue, the consumer-products company spun out of Johnson & Johnson last year, The Wall Street Journal reported on Oct. 20. The hedge fund believes the Tylenol- and Listerine-maker has some of the best consumer brands in its industry, but its stock has underperformed peers and the broader market since its debut, the Journal reported. The Wall Street Journal ? 22 days ago KVUE TPR TSLA Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever. Investor's Business Daily ? 25 days ago KVUE PFE Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement After a year of relatively flat share price movement, two catalysts have finally emerged to drive the stock. GuruFocus.com ? 25 days ago KVUE Starboard Focused on Kenvue's Struggling Unit Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he believes is weighing on the company's overall performance. The Wall Street Journal ? 26 days ago KVUE Starboard says Kenvue's skin health segment weighing on performance (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster growth is the reason for the stock's underperformance. Starboard Chief Investment Officer Jeffrey Smith said there is an opportunity to improve revenue growth and margins at the segment which has the Neutrogena and Aveeno brands. Kenvue has attributed the lackluster performance of its skin-health brands primarily to missteps around the placement of its products in stores. Reuters ? 26 days ago KVUE Starboard Value Buys Into Dow Jones Spinoff; ELF Beauty Rallies Kenvue stock rallied sharply Monday on reports that activist investor Starboard Value established a substantial stake in the consumer products company, which was spun out of Johnson & Johnson last year. Investor's Business Daily ? 26 days ago KVUE ELF JNJ Kenvue stock jumps on reports of Starboard Value's stake Activist investor Starboard Value, which in recent months has taken stakes in coffee chain Starbucks (SBUX) and pharmaceutical giant Pfizer (PFE), has set its sights on Kenvue (KVUE). The Wall Street Journal reported Starboard taking a "sizable stake" in the Tylenol and Band-Aids maker and hopes to boost its stock price. Shares move higher in Monday's pre-market trading. Morning Brief anchors Madison Mills and Seana Smith report more on this development for the consumer health product brand. Kenvue spun off from Johnson & Johnson (JNJ) in 2023. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan. Yahoo Finance Video ? 27 days ago KVUE What’s News: Business & Finance WHATS NEWS BUSINESS FINANCE Kelly Ortberg, Boeing’s new CEO, is taking steps to slim down the aircraft maker to improve its perilous financial situation as the company awaits a decision by its largest union on whether to ratify a new labor contract. The Wall Street Journal ? 27 days ago KVUE Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make changes to boost its share price. The Wall Street Journal ? 27 days ago KVUE Kenvue (NYSE:KVUE) Is Paying Out A Dividend Of $0.205 The board of Kenvue Inc. ( NYSE:KVUE ) has announced that it will pay a dividend of $0.205 per share on the 27th of... Simply Wall St. ? 28 days ago KVUE Performance Overview Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return J4D.F S&P 500 YTD +20.13% +23.08% 1-Year +31.11% +30.58% 3-Year -7.02% +41.93%
